Holder snapshot 7 signals
Share change
+58,006,647
Put/Call ratio
3.3%
SEC-reported price per share
$1.90
Number of holders
69
Value change
+$109,842,474
Number of buys
41
Open additional details 1 more signal available
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
266,837,198

Security key

05280R100

Report period

Q4 2022

Institutions

69

Top holders

10

Ownership snapshot

Top reported holders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Blackstone Inc.
Disclosed value leader
Blackstone Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F Lead comparable stake: 6.7% Showing 1-6 of 15 holder rows.

Quick read

Blackstone Inc. leads the comparable SEC ownership view at 6.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Blackstone Inc.'s linked filing trail.
Comparable ownership Top 5
Blackstone Inc. 6.7%
Syncona Portfolio Ltd 2.8%
Nantahala Capital Management, LLC 2%
Frazier Life Sciences Management,... 1.4%
Tetragon Partners GP Ltd 1.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Blackstone Inc.
13F
Company
13F
6.7%
$38,489,000
17,985,611 shares
30 Sep 2022
Syncona Portfolio Ltd
13F
Company
13F
2.8%
$15,723,000
7,346,829 shares
30 Sep 2022
Nantahala Capital Management, LLC
13F
Company
13F
2%
$11,162,000
5,215,788 shares
30 Sep 2022
Frazier Life Sciences Management, L.P.
13F
Company
13F
1.4%
$8,018,000
3,746,857 shares
30 Sep 2022
Tetragon Partners GP Ltd
13F
Company
13F
1.1%
$6,504,000
3,039,381 shares
30 Sep 2022
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
13F
0.63%
$3,580,000
1,672,732 shares
30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
69
Shares
107,371,378
Rows available
69
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
62
Q4 2022 holders
69
Holder diff
7
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .